# US 2021/0330851 A1 · Face mask with enhanced uv-c sterilization flow path and low resistance to inhalation

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0330851 A1
- Document ID: US20210330851A1
- Status: Published application
- Kind: A1
- Application number: 16/860,888
- Filed: 2020-04-28
- Published: 2021-10-28
- Earliest claimed: 2020-04-28
- Inventors: Adam Warwick Bell
- Web page: https://patentgrep.com/patent/US20210330851A1

## CPC

- A61L 9/20: Ultraviolet radiation
- A41D 13/1192: {with antimicrobial agent}
- A62B 18/025: {Halfmasks (A62B23/02 takes precedence; surgical face masks A41D13/11)}
- A41D 2400/26: UV light protection
- A61L 2209/12: Lighting means
- A62B 23/02: for respirators
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A41D: OUTERWEAR; PROTECTIVE GARMENTS; ACCESSORIES
- A62B: DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING (valves specially adapted for medical use A61M39/00; life-saving devices, apparatus or methods specially adapted for use in water B63C9/00; divers' equipment B63C11/00; specially adopted for use with aircraft, e.g. parachutes, ejector seats, {B64D17/00, B64D25/10}; rescue devices peculiar to mining E21F11/00)

## Abstract

A face mask designed for easy breathability, incorporating a UV-C light source, designed to have a long air flow pathway and/or a long dwell time, designed to protect the wearer against disease-causing biological agents.

## Claims

### Claim 1

A mask adapted to destroy pathogens prior to inhalation into the upper respiratory tract of a person, wherein, upon inhalation, air is drawn from the outside of the mask, through a flow pathway, to the inside of the mask, and thereby exposed to a germicidal dose of UVC,
wherein the mask comprises a mask body with an approximately hemispherical in shape, and is adapted to fit over the nose and mouth of a user,
and wherein the mask comprises an outer surface and an inner surface,
an air inlet penetrating from the outer surface to the inner surface, wherein the air inlet is flowably connected to the flow pathway having a first end, through which the air enters, and a second end, from which the air exits towards the mouth and nose of the user, whereby, upon inhalation, external atmospheric air flows through the inlet, through the first end of the flow pathway, through the length of the flow pathway, to the second end of the flow pathway, and exits the flow pathway towards the mouth and nose of the user,
and wherein the mask further comprises a one-way valve positioned within the flow pathway that allows air to flow from the exterior to the interior of the mask, opening upon inhalation by the user (creating a negative pressure inside the mask), but closing upon exhalation of the user (creating a positive pressure inside the mask),
and wherein the mask further comprises one or more LED UVC light sources with a power rating from 0.5 mW to 12 W, each providing a wavelength of 200-280 nm, positioned within the mask, adapted to directly illuminate at least 85% of the total interior of the flow pathway,
And further comprising a power source electrically connected to the one or more LED UVC light sources,
and where the mask further comprises an exhalation vent, whereby exhaled air exits the mask, back into the atmosphere.

### Claim 2 (depends on 1)

The mask of claim 1 wherein, in use or in a test situation, the total pressure drop across the mask is less than 0.05 w.c.

### Claim 3 (depends on 2)

The mask of claim 2 wherein the flow pathway is at least 30 cm in total length.

### Claim 4 (depends on 2)

The mask of claim 2 wherein the flow pathway is at least 60 cm in total length.

### Claim 5 (depends on 4)

The mask of claim 4 wherein the one or more UVC LEDs has a power rating of 1 mW to 100 mW.

### Claim 6 (depends on 5)

The mask of claim 5 wherein the one or more UVC LEDs has a total optical power output of from 10 mW to 100 mW.

### Claim 7 (depends on 4)

The mask of claim 4 wherein the one or more UVC LEDs is powered by batteries with a total voltage of between 1.5V and 12V.

### Claim 8 (depends on 3)

The mask of claim 3 wherein, when in use, the one or more UVC LEDs provides an average power output over the interior surface area of the flow path from 0.09 mW/cm2 to 24 mW/cm2.

### Claim 9 (depends on 3)

The mask of claim 3 wherein, when in use, the one or more UVC LEDs provides an average power output over the interior surface area of the flow path from 1 mW/cm2 to 4 mW/cm2.

### Claim 10 (depends on 3)

The mask of claim 3 having a killing efficiency of >90% when the pathogen is an influenza virus at 25 centigrade and 20% humidity.

### Claim 11 (depends on 3)

The mask of claim 3 wherein the flow pathway comprises a number of approximately parallel pathways contiguously connected to each other and positioned in such a way with relation to the UVC LED such that at least 90% of the interior of the flow pathway is directly illuminated by UVC light.

### Claim 12 (depends on 3)

The mask of claim 3 wherein the flow pathway comprises a number pathways arranged to radiate outwards from a central UVC source and positioned in such a way with relation to the UVC LED such that at least 90% of the interior of the flow pathway is directly illuminated by UVC light.

### Claim 13 (depends on 2)

The mask of claim 2 wherein the flow pathway comprises two chambers, (1) an inhalation chamber proximal to the user, covering the user's nose and mouth, (2) a sterilizing anti-chamber, distal to the user, and a valve located between these two chambers, wherein the useable volume of the sterilizing anti-chamber is between 0.5 and 0.75 litres, and wherein the valve closes when the user breathes out and opens when the user breathes in, thereby pulling a volume of air from the sterilizing anti-chamber into the inhalation chamber, and simultaneously pulling an equal volume of air from the outside into the sterilizing anti-chamber, wherein the one or more UVC LEDs produces a peak wavelength between 200 nm to 280 nm, and wherein the UVC LED has a power rating of not more than 4 W.

### Claim 14 (depends on 13)

The mask of claim 13 wherein the one or more UVC LEDs produce a peak wavelength of between 250 nm and 280 nm, with a total optical power output of from 10 mW to 100 mW.

### Claim 15 (depends on 14)

The mask of claim 14 wherein the one or more UVC LEDs is powered by batteries having a total voltage of between 1.5V as 12V.

### Claim 16 (depends on 14)

The mask of claim 14 wherein the sterilizing anti-chamber comprises on an inner surface, a reflective material that has a greater than 90% reflectivity for UVC.

### Claim 17 (depends on 16)

The mask or claim 16 wherein the reflective material is e-PTFE.

### Claim 18 (depends on 16)

The mask of claim 16 wherein the one or more UVC LEDs have the following specifications: forward current=500 mA; forward voltage=8.5V; radiant flux=70 mW; power dissipation=4.25 W; and Peak Wavelength=270-285 nm.

### Claim 19 (depends on 16)

The mask of claim 16 having a killing efficiency of >90% when the pathogen is an influenza virus at 25 Centigrade and 20% humidity.

### Claim 20 (depends on 16)

Than mask of claim 16 is rated with a total air resistance in use of from 0.01 to 0.25 inches w.c.
